Page last updated: 2024-10-24

carteolol and Kidney Diseases

carteolol has been researched along with Kidney Diseases in 2 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"In order to determine the appropriate dosage of carteolol in renal dysfunction, the pharmacokinetics of carteolol has been examined in appropriate patients."1.28Pharmacokinetics of carteolol in patients with impaired renal function. ( Amemiya, M; Asano, Y; Furuya, H; Sakairi, Y; Tabei, K, 1992)
" In healthy subjects the half-life of carteolol was 7."1.27Pharmacokinetics of carteolol in relation to renal function. ( Hasenfuss, G; Just, H; Knauf, H; Mutschler, E; Schäfer-Korting, M, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amemiya, M1
Tabei, K1
Furuya, H1
Sakairi, Y1
Asano, Y1
Hasenfuss, G1
Schäfer-Korting, M1
Knauf, H1
Mutschler, E1
Just, H1

Other Studies

2 other studies available for carteolol and Kidney Diseases

ArticleYear
Pharmacokinetics of carteolol in patients with impaired renal function.
    European journal of clinical pharmacology, 1992, Volume: 43, Issue:4

    Topics: Adult; Aged; Carteolol; Chronic Disease; Creatinine; Diabetic Nephropathies; Female; Glomerulonephri

1992
Pharmacokinetics of carteolol in relation to renal function.
    European journal of clinical pharmacology, 1985, Volume: 29, Issue:4

    Topics: Adult; Aged; Carteolol; Creatinine; Female; Half-Life; Humans; Kidney; Kidney Diseases; Kinetics; Ma

1985